BMAC

BIOLOGICAL4 trials

Sponsors

Harvest Technologies, University Hospital Ostrava, Massachusetts General Hospital, Istituto Ortopedico Rizzoli

Conditions

Acetabular Labrum TearAnkle OsteoarthritisBone Marrow Aspirate ConcentrateChondral DefectCongestive Heart FailureFemoro Acetabular ImpingementHeart FailureMesenchymal Stromal Cell

Phase 1

Feasibility Study of BMAC Enhanced CABG

TerminatedNCT01074099

Harvest TechnologiesCongestive Heart Failure

Start: 2011-02-28End: 2013-04-30Updated: 2016-01-18

Phase 2

Retrograde Application of Bone Marrow Aspirate Concentrate

CompletedNCT03372954

University Hospital OstravaHeart Failure

Start: 2018-01-01End: 2021-12-31Updated: 2022-12-09

Unknown Phase

Use of BMAC With Hip Arthroscopy Treatment of FAI and Labral Tear

RecruitingNCT03909139

Massachusetts General HospitalAcetabular Labrum Tear, Bone Marrow Aspirate Concentrate, Chondral Defect +2

Start: 2019-09-06End: 2027-06-30Target: 400Updated: 2025-10-27

Evaluation of the Single Injection of BMAC vs HA in the Treatment of the Ankle Osteoarthritis

TerminatedNCT04883892

Istituto Ortopedico RizzoliAnkle Osteoarthritis

Start: 2021-12-15End: 2025-08-11Updated: 2025-08-17

Related Papers

Rationale and design of a prospective, randomised study of retrograde application of bone marrow aspirate concentrate (BMAC) through coronary sinus in patients with congestive heart failure of ischemic etiology (the RETRO study)

BMC Cardiovascular Disorders2019-01-312 citations